GET THE APP

Respiratory Tract Infectious Disease and Laboratory Diagnostic Methods
..

Clinical Infectious Diseases: Open Access

ISSN: 2684-4559

Open Access

Commentary - (2022) Volume 6, Issue 5

Respiratory Tract Infectious Disease and Laboratory Diagnostic Methods

Amit Kuila*
*Correspondence: Amit Kuila, Maternity and Pediatric Nursing, University of Navarra, Spain, Email:
Maternity and Pediatric Nursing, University of Navarra, Spain

Received: 06-Sep-2022, Manuscript No. JID-22-75801; Editor assigned: 11-Sep-2022, Pre QC No. P-75801; Reviewed: 22-Sep-2022, QC No. Q-75801; Revised: 26-Sep-2022, Manuscript No. R-75801; Published: 29-Sep-2022 , DOI: 10.37421/2684-4559.2022.6.182
Citation: Kuila, Amit. “Respiratory Tract Infectious Disease and Laboratory Diagnostic Methods.” Clin Infect Dis 6 (2022): 182.
Copyright: © 2022 Kuila A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Asymptomatic or mild infection to severe or fatal disease are on the clinical spectrum. In order to provide patients with adequate and timely management, speed in diagnostics is necessary. The current algorithm for the laboratory diagnosis of RTIs uses both innovative molecular techniques, which are primarily used to detect viruses and atypical bacteria, as well as gold-standard conventional methods, the most popular of which is traditional culture. Despite the need for proper application of the exam in patients with a variety populations, the use of molecular techniques with symptomatic frames has the potential to be a potent decision-making tool for clinical outcomes. Asymptomatic or mild infection to severe or fatal disease is on the clinical spectrum. In order to provide patients with adequate and timely management, speed in diagnostics is necessary. The current algorithm for the laboratory diagnosis of RTIs uses both innovative molecular methods, which are primarily used it to detect viruses and atypical bacteria, as well as gold-standard conventional methods, the most popular of which is traditional culture.

Despite the need for proper application of the test in various patient populations, the use of molecular techniques with symptomatic frames has the potential to be a potent decision-making tool for patient management. Compared to traditional methods, their use drastically shortens the time to results and increases the detection of clinically relevant pathogens. Syndromic panels can also enhance antimicrobial use, patient outcomes, and laboratory workflow when used sensibly and interpretively.

Discussion

The main etiological, clinical, and epidemiological characteristics of RTI are described in this review in narrative form, with an emphasis on laboratory diagnosis and the potential of syndromic panels. Given their widespread prevalence and the high rates of morbidity and mortality they are associated with, respiratory tract infections are the focus of recent advancements in public health. RTIs are illnesses with an infectious aetiology that affect the respiratory system [1]. The severity of the illness depends on the interaction of three factors, including the causative agent, the host, and the environmental conditions, ranging from asymptomatic or mild infection to severe or fatal disease.

The majority of the time, these infections manifest as an acute disease with symptoms that really can appear hours or days after the infection, including fever, coughing, sore throats, coryza, shortness of breath, wheezing, and/ or breathing difficulties. Rapid sociodemographic changes and undoubtedly climate change have both had an impact on the epidemiology of RTIs. RTIs are reported to have a significant impact on the rising demand for medical examinations at both medical offices and emergency departments, on the prescription of antibiotics, and on hospital admissions [2]. They are also the most common reason for consultation or admission to health centers and primary care, especially among children and the elderly.

In order to provide crucial tools for health policies of control and prevention, the epidemiological study of RTIs must keep up with the swift changes in sociodemographic and climate dynamics and requires constant updating. To support and direct clinical decisions in favour of appropriate patient management while also avoiding the inappropriate use of antibiotics, a quick and accurate laboratory diagnosis of RTIs is necessary [3]. The misuse of broad-spectrum empirical therapy could actually result in the emergence and spread of antimicrobial-resistant pathogens, which would have a negative impact on clinical outcomes, raise mortality rates, and lengthen hospital stays. With the development of new tools for the detection of bacterial and viral respiratory infections over the years, significant technological advancements have led to the creation of precise, quick, and user-friendly diagnostic techniques. Molecular techniques in particular are now widely used in diagnostic laboratories. Without the lengthy incubation period required for bacterial or viral isolation, these molecular-based techniques enable sensitive and highly specific detection of both bacterial and viral nucleic acids directly in clinical specimens and in cell culture supernatants [4].

Additionally, molecular techniques require less technical knowledge than culture and are helpful for the detection of viruses and "difficult to grow" bacteria that do not multiply in conventional cell cultures. Since syndromic panels offer a highly potent tool capable of detecting a wide range of pathogens that, collectively, may cause a single clinical syndrome, their introduction in this context marked a significant advancement in the field of diagnostic microbiology. This was accomplished by meeting the demands for accuracy and a reduction in time-to-result. The main etiological, clinical, and epidemiological characteristics of RTIs are described in this review in narrative form, with an emphasis on laboratory diagnosis and the potential of syndromic panels. Additionally, this type of infection is acknowledged for significantly reducing life expectancy due to high rates of approximate disability-adjusted life years each year. At both a demographic and geographic level, the disease burden of RTIs exhibits an asymmetric distribution and varies greatly by age, gender, and between nations and regions. RTIs have a detrimental effect on life quality, especially for infants, kids, and the elderly, that also have the highest mortality and morbidity rates, particularly in low- and middle-income countries [5].

The populations of children and the elderly are both been the most vulnerable to RTIs globally in terms of mortality and loss of LE. Children under the age of one are said to have the highest mortality and DALY prices in the pediatric age group, whereas individuals over the age of 70 are accountable for the majority of deaths and loss of LE in the elderly population. The spatial variation of RTIs exhibits a similar disparity in terms of demographic distribution, which is largely influenced by the level of socioeconomic development. The highest mortality and DALY rates are found in low- and middle-income nations and territories, in which RTIs are more common. The risk of infection as well as hospital stays is higher for a large number of elderly people in high-income countries, where high ageing indices are taken into account. It is important to note that many RTI-related deaths throughout high-income nations take place in nursing homes and aged-care facilities; this suggests a high rate of RTI transmission in these settings, with reported high mortality rates and loss of LE for the elderly.

Conclusion

This review focuses on the technologies currently employed for the laboratory diagnosis of infectious respiratory diseases and demonstrates that no single approach, including molecular detection, antigen identification, and virus isolation, can meet the needs of all diagnostic virology laboratories in all clinical scenarios involving all varieties of viruses. Clinical microbiologists and virologists are challenged to use the technology that is currently available that best fits the particular scenario and yields the most useful results. They also need to generate clinical news stories that can direct physicians toward the best way to interpret the results for the best patient management.

Conflict of Interest

None.

References

  1. She, Rosemary C., Mindy L. Rawlins, Ramsey Mohl and Sherrie L. Perkins, et al. “Comparison of Immunofluorescence Antibody Testing and Two Enzyme Immunoassays in the Serologic Diagnosis of Malaria.” J Travel Med 14 (2007):105–111.
  2. Google Scholar, Crossref

  3. Zoboli, Fabio, Diego Ripamonti, Simone V. Benatti and Laura Comi,et al. “Autoimmune hepatitis and HIV infection: two case reports and review of the literature.”  AIDS 31 (2017): 2172-2175.
  4. Google Scholar, Crossref

  5. Le Saux, Nicole, Julie A. Bettinger, Scott A. Halperin and Wendy Vaudry, et al. “Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005–2007 IMPACT surveillance in Canadian hospitals.” Pediatr Infect Dis J 29 (2010):879–882.
  6. Google Scholar, Crossref

  7. Newman, Robert D., Jacqueline Grupp-Phelan, David K. Shay and Robert L. Davis. “Perinatal risk factors for infant hospitalization with viral gastroenteritis.”  Pediatrics 103 (1999): e3-e3.
  8. Google Scholar, Crossref

  9. Blutt, Sarah E., Carl D. Kirkwood, Viviana Parreño and Kelly L. Warfield, et al. “Rotavirus antigenaemia and viraemia: a common event? Lancet.”  362 (2003): 1445–1449.
  10. Google Scholar, Crossref

arrow_upward arrow_upward